mTOR overexpression was detected in 23% (33/142) of the tumours, predominantly with high nuclear grade tumours (P=0.034), and in association with α-IGF1R (47% P<0.000), p110α (64% P=0.028) and pBad (65% P=0.027). Here, MTOR is linked to neoplasm.